Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TSU-68 plus docetaxel vs docetaxel in metastatic breast cancer after anthracycline
jRCT2080221367Phase 2
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of orantinib in breast cancer (2 arms), sponsored by Taiho Pharmaceutical Co., Ltd.
02
Drugs
orantinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on jRCT2080221367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221367.